Annual Cost Of Goods Sold
$33.77 M
+$12.13 M+56.08%
31 December 2023
Summary:
Nektar Therapeutics annual cost of goods sold is currently $33.77 million, with the most recent change of +$12.13 million (+56.08%) on 31 December 2023. During the last 3 years, it has risen by +$14.29 million (+73.37%). NKTR annual cost of goods sold is now -77.11% below its all-time high of $147.52 million, reached on 31 December 2007.NKTR Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$4.43 M
-$5.30 M-54.47%
30 September 2024
Summary:
Nektar Therapeutics quarterly cost of goods sold is currently $4.43 million, with the most recent change of -$5.30 million (-54.47%) on 30 September 2024. Over the past year, it has dropped by -$8.00 million (-64.32%). NKTR quarterly cost of goods sold is now -92.15% below its all-time high of $56.52 million, reached on 31 March 2007.NKTR Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$29.99 M
-$8.00 M-21.05%
30 September 2024
Summary:
Nektar Therapeutics TTM cost of goods sold is currently $29.99 million, with the most recent change of -$8.00 million (-21.05%) on 30 September 2024. Over the past year, it has dropped by -$2.73 million (-8.33%). NKTR TTM cost of goods sold is now -82.18% below its all-time high of $168.33 million, reached on 30 June 2007.NKTR TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.1% | -64.3% | -8.3% |
| 3 y3 years | +73.4% | -16.5% | +30.1% |
| 5 y5 years | +38.3% | -10.0% | +31.3% |
NKTR Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +73.4% | -64.3% | at low | -21.1% | +39.1% |
| 5 y | 5 years | at high | +73.4% | -64.3% | +16.4% | -21.1% | +54.0% |
| alltime | all time | -77.1% | +2914.0% | -92.2% | +223.2% | -82.2% | +6098.4% |
Nektar Therapeutics Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.43 M(-54.5%) | $29.99 M(-21.0%) |
| June 2024 | - | $9.74 M(+14.1%) | $37.99 M(+7.8%) |
| Mar 2024 | - | $8.53 M(+17.2%) | $35.24 M(+4.4%) |
| Dec 2023 | $33.77 M(+56.1%) | $7.28 M(-41.4%) | $33.77 M(+3.2%) |
| Sept 2023 | - | $12.43 M(+77.7%) | $32.72 M(+29.5%) |
| June 2023 | - | $6.99 M(-0.9%) | $25.26 M(+8.0%) |
| Mar 2023 | - | $7.06 M(+13.3%) | $23.38 M(+8.1%) |
| Dec 2022 | $21.64 M(-13.1%) | $6.23 M(+25.4%) | $21.64 M(+0.3%) |
| Sept 2022 | - | $4.97 M(-2.8%) | $21.57 M(-1.5%) |
| June 2022 | - | $5.12 M(-3.8%) | $21.90 M(-10.4%) |
| Mar 2022 | - | $5.32 M(-13.8%) | $24.46 M(-1.8%) |
| Dec 2021 | $24.90 M(+27.8%) | $6.16 M(+16.0%) | $24.90 M(+8.0%) |
| Sept 2021 | - | $5.31 M(-30.7%) | $23.06 M(-1.1%) |
| June 2021 | - | $7.67 M(+33.2%) | $23.32 M(+8.8%) |
| Mar 2021 | - | $5.76 M(+33.1%) | $21.42 M(+10.0%) |
| Dec 2020 | $19.48 M(-8.9%) | $4.32 M(-22.4%) | $19.48 M(-7.9%) |
| Sept 2020 | - | $5.57 M(-3.5%) | $21.14 M(+3.1%) |
| June 2020 | - | $5.77 M(+51.5%) | $20.50 M(+3.8%) |
| Mar 2020 | - | $3.81 M(-36.4%) | $19.75 M(-7.6%) |
| Dec 2019 | $21.37 M(-12.4%) | $5.99 M(+21.6%) | $21.37 M(-6.4%) |
| Sept 2019 | - | $4.93 M(-1.8%) | $22.85 M(+0.6%) |
| June 2019 | - | $5.02 M(-7.8%) | $22.70 M(-2.2%) |
| Mar 2019 | - | $5.44 M(-27.1%) | $23.21 M(-4.9%) |
| Dec 2018 | $24.41 M(-20.1%) | $7.46 M(+56.0%) | $24.41 M(-8.6%) |
| Sept 2018 | - | $4.78 M(-13.4%) | $26.70 M(-3.2%) |
| June 2018 | - | $5.52 M(-16.9%) | $27.59 M(-11.2%) |
| Mar 2018 | - | $6.65 M(-31.9%) | $31.06 M(+1.7%) |
| Dec 2017 | $30.55 M(+1.1%) | $9.75 M(+71.9%) | $30.55 M(+11.5%) |
| Sept 2017 | - | $5.67 M(-36.9%) | $27.40 M(-4.7%) |
| June 2017 | - | $8.99 M(+46.6%) | $28.76 M(+4.7%) |
| Mar 2017 | - | $6.13 M(-7.2%) | $27.48 M(-9.1%) |
| Dec 2016 | $30.21 M(-11.4%) | $6.60 M(-6.1%) | $30.21 M(-5.5%) |
| Sept 2016 | - | $7.03 M(-8.8%) | $31.98 M(+0.9%) |
| June 2016 | - | $7.71 M(-13.1%) | $31.70 M(-8.2%) |
| Mar 2016 | - | $8.87 M(+6.0%) | $34.53 M(+1.2%) |
| Dec 2015 | $34.10 M(+19.5%) | $8.36 M(+23.7%) | $34.10 M(+6.4%) |
| Sept 2015 | - | $6.76 M(-35.8%) | $32.04 M(-7.1%) |
| June 2015 | - | $10.53 M(+24.8%) | $34.50 M(+18.7%) |
| Mar 2015 | - | $8.44 M(+34.1%) | $29.07 M(+1.9%) |
| Dec 2014 | $28.53 M(-25.9%) | $6.30 M(-31.7%) | $28.53 M(-8.5%) |
| Sept 2014 | - | $9.22 M(+80.5%) | $31.20 M(-10.5%) |
| June 2014 | - | $5.11 M(-35.4%) | $34.85 M(+0.3%) |
| Mar 2014 | - | $7.91 M(-11.8%) | $34.76 M(-9.7%) |
| Dec 2013 | $38.51 M(+26.6%) | $8.96 M(-30.4%) | $38.51 M(+4.5%) |
| Sept 2013 | - | $12.88 M(+157.0%) | $36.84 M(+18.1%) |
| June 2013 | - | $5.01 M(-57.0%) | $31.19 M(-6.6%) |
| Mar 2013 | - | $11.66 M(+60.0%) | $33.38 M(+9.7%) |
| Dec 2012 | $30.43 M | $7.29 M(+0.9%) | $30.43 M(+6.4%) |
| Sept 2012 | - | $7.23 M(+0.3%) | $28.59 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $7.20 M(-17.3%) | $26.40 M(-3.4%) |
| Mar 2012 | - | $8.71 M(+59.8%) | $27.34 M(+24.9%) |
| Dec 2011 | $21.89 M(-14.7%) | $5.45 M(+8.2%) | $21.89 M(-17.9%) |
| Sept 2011 | - | $5.04 M(-38.1%) | $26.68 M(-4.3%) |
| June 2011 | - | $8.14 M(+149.5%) | $27.89 M(+13.2%) |
| Mar 2011 | - | $3.26 M(-68.1%) | $24.63 M(-4.0%) |
| Dec 2010 | $25.67 M(-17.1%) | $10.24 M(+63.9%) | $25.67 M(+5.9%) |
| Sept 2010 | - | $6.25 M(+27.7%) | $24.24 M(+0.5%) |
| June 2010 | - | $4.89 M(+13.8%) | $24.13 M(-18.5%) |
| Mar 2010 | - | $4.30 M(-51.2%) | $29.62 M(-4.3%) |
| Dec 2009 | $30.95 M(-11.7%) | $8.81 M(+43.6%) | $30.95 M(-4.3%) |
| Sept 2009 | - | $6.13 M(-40.9%) | $32.34 M(+2.5%) |
| June 2009 | - | $10.38 M(+84.5%) | $31.55 M(+12.3%) |
| Mar 2009 | - | $5.63 M(-44.8%) | $28.10 M(-19.8%) |
| Dec 2008 | $35.04 M(-76.2%) | $10.20 M(+90.6%) | $35.04 M(-28.3%) |
| Sept 2008 | - | $5.35 M(-22.8%) | $48.89 M(-31.1%) |
| June 2008 | - | $6.93 M(-44.8%) | $71.00 M(-31.4%) |
| Mar 2008 | - | $12.56 M(-47.8%) | $103.56 M(-29.8%) |
| Dec 2007 | $147.52 M(+24.9%) | $24.05 M(-12.4%) | $147.52 M(-10.4%) |
| Sept 2007 | - | $27.46 M(-30.5%) | $164.61 M(-2.2%) |
| June 2007 | - | $39.49 M(-30.1%) | $168.33 M(+1.6%) |
| Mar 2007 | - | $56.52 M(+37.4%) | $165.62 M(+40.2%) |
| Dec 2006 | $118.09 M(+397.7%) | $41.14 M(+32.0%) | $118.09 M(+55.7%) |
| Sept 2006 | - | $31.18 M(-15.2%) | $75.83 M(+40.8%) |
| June 2006 | - | $36.77 M(+308.8%) | $53.85 M(+113.9%) |
| Mar 2006 | - | $8.99 M(-903.1%) | $25.17 M(+6.1%) |
| Dec 2005 | $23.73 M(+19.9%) | -$1.12 M(-112.2%) | $23.73 M(-23.2%) |
| Sept 2005 | - | $9.20 M(+13.6%) | $30.90 M(+18.0%) |
| June 2005 | - | $8.10 M(+7.3%) | $26.18 M(+5.5%) |
| Mar 2005 | - | $7.55 M(+24.7%) | $24.81 M(+25.3%) |
| Dec 2004 | $19.80 M(+34.9%) | $6.05 M(+35.2%) | $19.80 M(+19.6%) |
| Sept 2004 | - | $4.48 M(-33.5%) | $16.55 M(+6.0%) |
| June 2004 | - | $6.73 M(+165.5%) | $15.62 M(+24.0%) |
| Mar 2004 | - | $2.54 M(-9.7%) | $12.59 M(-14.2%) |
| Dec 2003 | $14.68 M(+109.1%) | $2.81 M(-20.7%) | $14.68 M(+9.6%) |
| Sept 2003 | - | $3.54 M(-4.5%) | $13.39 M(+13.6%) |
| June 2003 | - | $3.71 M(-19.8%) | $11.79 M(+20.9%) |
| Mar 2003 | - | $4.62 M(+204.7%) | $9.75 M(+38.9%) |
| Dec 2002 | $7.02 M(+68.4%) | $1.52 M(-21.8%) | $7.02 M(-8.7%) |
| Sept 2002 | - | $1.94 M(+16.0%) | $7.69 M(-0.5%) |
| June 2002 | - | $1.67 M(-11.5%) | $7.73 M(+27.6%) |
| Mar 2002 | - | $1.89 M(-13.7%) | $6.06 M(+45.3%) |
| Dec 2001 | $4.17 M(-447.4%) | $2.19 M(+10.7%) | $4.17 M(+110.7%) |
| Sept 2001 | - | $1.98 M(-155.0%) | $1.98 M(-495.8%) |
| Dec 1996 | -$1.20 M(+9.1%) | - | - |
| Dec 1995 | -$1.10 M(+120.0%) | - | - |
| Dec 1994 | -$500.00 K | -$3.60 M(-427.3%) | -$500.00 K(-116.1%) |
| Sept 1994 | - | $1.10 M(+10.0%) | $3.10 M(+55.0%) |
| June 1994 | - | $1.00 M(0.0%) | $2.00 M(+100.0%) |
| Mar 1994 | - | $1.00 M | $1.00 M |
FAQ
- What is Nektar Therapeutics annual cost of goods sold?
- What is the all time high annual cost of goods sold for Nektar Therapeutics?
- What is Nektar Therapeutics annual cost of goods sold year-on-year change?
- What is Nektar Therapeutics quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly cost of goods sold year-on-year change?
- What is Nektar Therapeutics TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Nektar Therapeutics?
- What is Nektar Therapeutics TTM cost of goods sold year-on-year change?
What is Nektar Therapeutics annual cost of goods sold?
The current annual cost of goods sold of NKTR is $33.77 M
What is the all time high annual cost of goods sold for Nektar Therapeutics?
Nektar Therapeutics all-time high annual cost of goods sold is $147.52 M
What is Nektar Therapeutics annual cost of goods sold year-on-year change?
Over the past year, NKTR annual cost of goods sold has changed by +$12.13 M (+56.08%)
What is Nektar Therapeutics quarterly cost of goods sold?
The current quarterly cost of goods sold of NKTR is $4.43 M
What is the all time high quarterly cost of goods sold for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly cost of goods sold is $56.52 M
What is Nektar Therapeutics quarterly cost of goods sold year-on-year change?
Over the past year, NKTR quarterly cost of goods sold has changed by -$8.00 M (-64.32%)
What is Nektar Therapeutics TTM cost of goods sold?
The current TTM cost of goods sold of NKTR is $29.99 M
What is the all time high TTM cost of goods sold for Nektar Therapeutics?
Nektar Therapeutics all-time high TTM cost of goods sold is $168.33 M
What is Nektar Therapeutics TTM cost of goods sold year-on-year change?
Over the past year, NKTR TTM cost of goods sold has changed by -$2.73 M (-8.33%)